Dame Kate Bingham Celebrates ‘Astonishing’ $3bn Deal for EyeBio
In a landmark deal for the biotech industry, US pharmaceutical giant Merck, known as MSD in the UK, has acquired EyeBio, a London-based startup co-founded by Dame Kate Bingham, for up to $3bn (£2.36bn). . .This acquisition is expected…